Caregiver burden and its determinants among family members of patients with chronic viral hepatitis in Shanghai, China: a community-based survey

BMC Infectious Diseases

Wei Meng²  Yi-Han Lu²  Yang Shi¹  Jia-Yu Hu¹  Yan Yu³  Hong Ren¹ 

[1] Department of Infectious Disease Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China;Department of Epidemiology, The Key Laboratory of Public Health Safety of Minister of Education, Fudan University School of Public Health, Building 8 Room 429,130 Dong’an Road, Shanghai 200032, China;Department of Injury Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China

关键词: Reliability and validity;    The family burden interview schedule;    Family caregiver;    Chronic viral hepatitis;   

Others  :  1134654
DOI  :  10.1186/1471-2334-14-82

 received in 2013-09-25, accepted in 2014-02-11,  发布年份 2014

【 摘 要 】

Background

In China, caregivers of chronic viral hepatitis patients experience considerable burdens, stress and disruption of their own well-being and social activities. Measurement of the effect on caregivers is an under-researched area. The Family Burden Interview Schedule (FBIS) was primarily devised for the caregivers of schizophrenia patients, and the adverse effect of the disease was similar to the effect of chronic viral hepatitis on family caregivers. In this study, we prospectively evaluated the psychometric properties of FBIS in the field of chronic viral hepatitis and used it to determine the factors affecting the caregiver burden on the family members of chronic viral hepatitis patients in Shanghai, China.

Methods

A representative sample of patients (n = 1478) and caregivers (n = 1478) was randomly obtained through a multi-stage cluster sampling in Shanghai, China. Reliability and validity tests were used to verify the psychometric properties of the instrument. The two-level random intercept model was applied to determine the factors of the caregiver burden between the household and the community level.

Results

Cronbach’s alpha coefficient was 0.90 for the overall instrument with statistical significance. Factor analysis suggested a three-factor model for the FBIS and confirmed that the adjusted unidimensional model and the second-order multidimensional model had better fit statistics. The average score of the caregiver burden in Shanghai was 12.62 ± 10.74, and financial burden constituted the major effect. The two-level random intercept model demonstrated that the risk factors were hospitalisation (β 1.69, 95%CI 0.48 to 2.90), elevated serum alanine aminotransferase levels (β 1.05, 95%CI 0.15 to 1.95), HCV infection (β 4.49, 95%CI 1.22 to 7.77), and acceptance of the hepatitis B vaccine (β 2.20, 95%CI 0.56 to 3.85), whereas the protective factors were no consumption of alcohol (β -2.69, 95%CI −5.19 to −0.19), average monthly costs for patients less than or equal to 100 US dollars (β -2.96, 95%CI −5.83 to −0.09), and good health status of family caregivers (β -9.91, 95%CI −12.76 to −7.05).

Conclusions

FBIS can accurately measure the caregiver burden for chronic hepatitis. Targeting interventions toward the conditions associated with the caregiver burden is of great importance.

【 授权许可】

   
2014 Ren et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Lavanchy D: Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005, 34(Suppl):S1-S3.
• [2]Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5:558-567.
• [3]Nguyen LH, Nguyen MH: Systematic review: Asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther 2013, 37(10):921-936.
• [4]Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M: Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol 2011, 21(6):401-416.
• [5]Sun Z, Ming L, Zhu X, Lu J: Prevention and control of hepatitis B in China. J Med Virol 2002, 67(3):447-450.
• [6]Huang C, Qiu F, Guo M, Yi Y, Shen L, Wang F, Jia Z, Ma J, Zhao Y, Zhang S, Zhang Y, Bi S: Prevalence and risk factors of hepatitis C among former blood donors in rural China. Int J Infect Dis 2012, 16(10):e731-e734.
• [7]Annandale: The Sociology of Health and Medicine: a critical introduction. Cambridge: Polity Press; 1998.
• [8]Barkow J, Cosmides L, Tooby J: The adapted mind: evolutionary psychology and the generation of culture. Oxford: Oxford University Press; 1992.
• [9]Pai S, Kaipur RL: The burden on the family of a psychiatric patient: development of an interview schedule. Br J Psychiatry 1981, 138:332-335.
• [10]Grover S, Dutt A: Perceived burden and quality of life of caregivers in obsessive-compulsive disorder. Psychiatry Clin Neurosci 2011, 65(5):416-422.
• [11]Mattoo SK, Nebhinani N, Kumar BA, Basu D, Kulhara P: Family burden with substance dependence: a study from India. Indian J Med Res 2013, 137(4):704-711.
• [12]Martorell A, Pereda A, Salvador-Carulla L, Ochoa S, Ayuso-Mateos JL: Validation of the Subjective and Objective Family Burden Interview (SOFBI/ECFOS) in primary caregivers to adults with intellectual disabilities living in the community. J Intellect Disabil Res 2007, 51(Pt 11):892-901.
• [13]Chien WT, Norman I: The validity and reliability of a Chinese version of the family burden interview schedule. Nurs Res 2004, 53(5):314-322.
• [14]Chen H, Meng H, Lu ZX: Prospective study on family burden following traumatic brain injury in children. Zhonghua Liu Xing Bing Xue Za Zhi 2006, 27(4):307-310.
• [15]Duan QH, Xu YC, Liang XY, Yuan XB, Zhao HH, Ran P: Study on the reliability, validity and sensitivity of a family burden scale used for evaluation on schistosomiasis. Zhonghua Liu Xing Bing Xue Za Zhi 2008, 29(12):1189-1192.
• [16]Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association: Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J (Engl) 2007, 120(24):2159-2173.
• [17]Ghany MG, Strader DB, Thomas DL, Seeff LB: American association for the study of liver diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49(4):1335-1374.
• [18]Hepatotogy Branch, Infectious and Parasitology branch, Chinese Medical Association: Guideline of prevention and treatment of hepatitis C. Zhonghua Yu Fang Yi Xue Za Zhi 2004, 38(3):210-215.
• [19]Nunnally J, Bernstein I: Psychometric Theory. New York: McGraw-Hill; 1994.
• [20]Ware JE, Gandek B: Methods for testing data quality, scaling assumptions, and reliability: The IQ-QLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:945-952.
• [21]Jacob C, Patricia C, Stephen GW, Leona SA: Applied multiple regression and correlation analysis for the behavioral sciences. 3rd edition. London: Lawrence Eribaum Associates; 2003.
• [22]Jolloffe IT: Principal Components Analysis. 2nd edition. New York: Springer; 2002.
• [23]Byrne BM: Structural Equation Modeling with Amos: Basic Concepts, Applications, and Programming. New Jersey: Lawrence Erlbaum Associates; 2001.
• [24]Goldstein H: Multilevel Statistical Models. 4th edition. London: Wiley; 2011.
• [25]Lu J, Xu A, Wang J, Zhang L, Song L, Li R, Zhang S, Zhuang G, Lu M: Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China. BMC Health Serv Res 2013, 13:37. BioMed Central Full Text
• [26]Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, Wu HY, Liang XS, Zhang P, Zhao JF, Tan XJ, Lu W, Schaefer S, Cao GW: Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut 2008, 57(12):1713-1720.
• [27]Li J, Liu JY, Hu JY, Li YT: Study on the status of HBV infection and its determinants among family members with HBV infected persons in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 2013, 34(3):205-209.
• [28]Tsang PS, Trinh H, Garcia RT, Phan JT, Ha NB, Nguyen H, Nguyen K, Keeffe EB, Nguyen MH: Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. Clin Gastroenterol Hepatol 2008, 6(5):569-574.
• [29]Lee M, Kowdley KV: Alcohol’s effect on other chronic liver diseases. Clin Liver Dis 2012, 16(4):827-837.
• [30]Hajarizadeh B, Grebely J, Dore GJ: Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013. [Epub ahead of print]
• [31]Na L, Na B: A revolutionary road: an analysis of persons living with hepatitis B in China. J Health Commun 2013, 18(1):71-91.